中国农业科技导报 ›› 2023, Vol. 25 ›› Issue (5): 147-157.DOI: 10.13304/j.nykjdb.2022.1052

• 动植物健康 • 上一篇    

金黄色葡萄球菌小菌落突变体诱导筛选及特性研究

周宇1(), 李佳玉1, 王乐1, 贾晓爽1, 高思琦1, 王潇2, 焦健1()   

  1. 1.北京城市学院生物医药学部,北京 100094
    2.宁波大学医学院,浙江 宁波 315211
  • 收稿日期:2022-12-02 接受日期:2023-02-01 出版日期:2023-05-20 发布日期:2023-07-13
  • 通讯作者: 焦健
  • 作者简介:周宇 E-mail:18201538379@163.com
  • 基金资助:
    国家自然科学基金青年项目(82002190);北京城市学院种子基金项目(KYZZ202005);大学生创新创业训练计划项目(202211418023)

Induction Screening and Characteristics of Staphylococcus aureus Small Colony Variants

Yu ZHOU1(), Jiayu LI1, Le WANG1, Xiaoshuang JIA1, Siqi GAO1, Xiao WANG2, Jian JIAO1()   

  1. 1.Department of Biomedicine,Beijing City University,Beijing 100094,China
    2.School of Medicine,Ningbo University,Zhejiang Ningbo 315211,China
  • Received:2022-12-02 Accepted:2023-02-01 Online:2023-05-20 Published:2023-07-13
  • Contact: Jian JIAO

摘要:

稳定型金黄色葡萄球菌(Staphylococcus aureus)小菌落突变体(small colony variants, SCVs)的获得,为抗SCVs药物的研究提供了重要的生物学材料。以S. aureus ATCC43300为出发菌株,利用低质量浓度(1.25~5.00 μg·mL-1)庆大霉素二次诱导技术获得稳定型SCVs,并对其特性进行分析。结果表明,1/2×最小抑菌浓度(minimum inhibitory concentration, MIC)及2×MIC庆大霉素分别诱导6 和12 h,可获得稳定型SCVs。SCVs生长缓慢,培养24 h可见较小菌落,培养7 h至生长对数期;对庆大霉素敏感性及产生物膜能力分别提高3和1倍;传代20次后恢复突变率为0%,抗逆性、药物敏感性、抗凝血性均增强,SigB调控系统及生物膜相关基因呈上调趋势,Agr调控系统及毒力因子下调。该方法的成功建立为SCVs的获得提出新的筛选策略,并为开展SCVs致病机理研究及新型抗SCVs药物研发提供稳定型受试菌株。

关键词: 金黄色葡萄球菌, 小菌落突变体, 庆大霉素

Abstract:

To obtain the small colony variants (SCVs) of Staphylococcus aureusS. aureus) is important biological materials for the research of anti-SCVs drugs. In this study, S. aureus ATCC43300 was used as the starting strain, the stable SCVs were obtained by secondary induction technique of low mass concentration (1.25~5.00 μg·mL-1) gentamicin,and their characteristics were analyzed. The results showed that the stable SCVs could be obtained by secondary induction at 1/2×minimum inhibitory concentration(MIC)gentamicin 6 hours and 2×MIC gentamicin 12 hours. SCVs grew slowly, small colonies could be seen after incubated for 24 hours, even took 7 hours to reach the exponential growth phase;the sensitivity to gentamicin and the ability to produce membrane were increased 3 and 1 times;the recovery mutation rate was 0% after successive 20 passages; anti-stress, drug sensitivity and anti-coagulation were all enhanced. The SigB regulatory systems and the biofilm-related genes were up-regulated, the Agr regulatory system and the virulence factors were down-regulated. This method proposed successful new screening strategy for screening SCVs, and also provided stable test strains for pathogenesis of SCVs and the development of novel anti-SCVs drugs.

Key words: Staphylococcus aureus, small colony variants(SCVs), gentamicin

中图分类号: